Wilmington Investor Network

Tunnel is a fintech company that offers real-time cross-currency payments services. The company utilizes a Distributed Ledger Technology (DLT) to offer no transaction fee processing. It also provides payment rails, APIs, and mobile apps. Frank Makrides, Mariana Jbantova Svirchuk, and Neil Ratna established Tunnel in Boston, Massachusetts in 2018.

Roobrik builds online assessment and decision tools for adults and their caregivers. The company prioritizes informed decision-making by offering assessment tools to older adults and families. Roobrik was founded in 2013 and is headquartered in Greensboro, North Carolina.

Respiratory Motion has a wide variety of patient populations and environments to assess respiratory function and provide early warning of respiratory collapse. It is a commercial-stage medical device company that specializes in the fields of medical devices, clinical evaluation and testing, manufacturing, and respiratory monitoring.

Meta Materials is a platform technology company that partners with OEMs across an expanding range of industries. Its extensive technology platform encompasses three core capabilities, holography, lithography, and wireless sensing, and is software and AI-design driven.

Avhana Health operates a value-based care enablement platform. It is driven by a mission to offer impactful, patient-specific support for healthcare teams. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Validic is a technology platform that offers digital health and remote care programs for healthcare organizations. It connects to over 400 in-home clinical and mobile health devices and applications. The company's mission is to improve the quality of human life by building technology that makes personal data actionable.

Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

Trusted Metrics provides Elastic SOC®, a multi-tenant, cloud-based platform which gives organizations of any size the ability to incorporate SIEM as a framework for centralized log correlation, as well as intrusion detection, asset management, vulnerability management, threat intelligence, alarm generation and network performance management into a single console. This solution was specifically designed with managed service providers (MSPs) and managed security service providers (MSSPs) in mind, giving them the ability to deploy a white-labeled virtual Security Operations Center (SOC) for their clients, enabling around-the-clock network security monitoring, protection and response. Elastic SOC® allows any organization the ability to quickly analyze threats, provide on-demand or scheduled reporting on IT Operations, receive real-time alerts when unfavorable conditions occur, or perform long-term forensic analysis. Proud to be named a Red Herring Global 100 Finalist for 2016 and CRN's Coolest Emerging Vendors for 2015 and 2016, we are dedicated to our channel partners by providing a multi-tenant offering that allows unprecedented visibility into their clients' networks.

ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.

Chaologix, Inc. is a technology company specializing in the development of computing architecture and chip sets. Founded in 2005 and based in Gainesville, Florida, the company focuses on creating processors and architectures that utilize chaotic circuit elements. Their flagship product, the Chaologix system, is applicable in various fields, including desktop and laptop computers, reconfigurable video cards for multimedia and gaming, network routers, chaotic search engine hardware, and advanced medical devices. Additionally, Chaologix technology supports robotics and aerospace applications, including those for NASA and the Department of Defense. The company emphasizes the importance of security in its semiconductor technology, which aims to deter side-channel attacks and enhance data protection, making its solutions relevant in an era of increasing cybersecurity concerns.

Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

OncoHealth designs screening devices that detects and diagnoses cancer. Its devices focus on the development of protein bio-markers for screening and diagnostics of cervical cancer and other HPV-associated cancers, enabling medical professionals to monitor, diagnose, and treat cancer.

Pique Therapeutics is a biopharmaceutical company seeking to become the leader in the development of new therapeutic vaccines, focused initially on the treatment of cancer.

Basho is a distributed systems company dedicated to making software that is highly available, fault-tolerant and easy-to-operate at scale. Basho’s distributed database, Riak, and Basho’s cloud storage software, Riak CS, are used by fast growing Web businesses and by one third of the Fortune 50 to power their critical Web, mobile and social applications and their public and private cloud platforms. Riak and Riak CS are open source platforms. Riak Enterprise and Riak CS Enterprise offer enhanced multi-datacenter replication and 24×7 Basho support.

Basho is a distributed systems company dedicated to making software that is highly available, fault-tolerant and easy-to-operate at scale. Basho’s distributed database, Riak, and Basho’s cloud storage software, Riak CS, are used by fast growing Web businesses and by one third of the Fortune 50 to power their critical Web, mobile and social applications and their public and private cloud platforms. Riak and Riak CS are open source platforms. Riak Enterprise and Riak CS Enterprise offer enhanced multi-datacenter replication and 24×7 Basho support.

Sensory Analytics, LLC develops advanced sensory solutions for precise measurement in various industrial applications, focusing on color and thickness measurement as well as process control. The company's flagship product line, SpecMetrix, includes automated and portable systems that deliver real-time, non-contact measurement of coating thickness, color, and other quality metrics. These systems provide continuous data with high precision, enabling industries such as aerospace, automotive, coatings, electronics, packaging, medical, and pharmaceuticals to enhance quality assurance and optimize production processes. Founded in 2004 and based in Greensboro, North Carolina, Sensory Analytics aims to improve process control and product quality while reducing operational costs through innovative measurement technologies.

Consolidated Asset Recovery Systems is a world-class SaaS company based in Raleigh, NC with 50 employees and offices in California, Texas, Colorado, and Florida. We have experienced growth upwards of 1600% and have helped top-tier lenders manage their underperforming assets more efficiently and effectively. The company was founded in 2005 by Steve Norwood and Terry Groves, two software supply chain veterans, whose vision continues to drive the company’s success. From the beginning, Steve and Terry decided to leverage SaaS technology to revolutionize the repossession and remarketing industry. This vision manifests itself in our strict adherence to compliant service providers, flexible business models and a comprehensive set of services. We create transparency and control, thereby helping lenders manage their brand and optimize outcomes. We are unlike other industry players because we adapt to the lenders’ way of doing business and provide both software and services. We have a long history of profitability. Our financial stability in the industry, makes us the partner of choice for many service providers such as repossession, skip trace, door knock and auction agents. This help us maintain the largest service provider network and ensures our standards for compliance are met. We continue to lead the market, with numerous industry and national awards.

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.

Affinergy develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces in order to kickstart biology toward an intended outcome. Affinergy is focused on developing coatings and medical devices for the orthopedic and cardiovascular markets. Affinergy's technology was patented at Duke University and the company has been incubated at Becton Dickinson's research center in Research Triangle Park. Affinergy was awarded 2005 Innovation of the Year by Frost & Sullivan in the category of Medical Device Coatings.